Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
The 200 bedded hospital owned & operated by Alexis
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
Subscribe To Our Newsletter & Stay Updated
